NYSE:GMED Globus Medical (GMED) Stock Price, News & Analysis $52.60 -0.03 (-0.06%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$52.65 +0.05 (+0.09%) As of 08/1/2025 06:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About Globus Medical Stock (NYSE:GMED) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Globus Medical alerts:Sign Up Key Stats Today's Range$51.79▼$52.9750-Day Range$51.94▼$61.3952-Week Range$51.79▼$94.93Volume1.65 million shsAverage Volume1.55 million shsMarket Capitalization$7.12 billionP/E Ratio39.25Dividend YieldN/APrice Target$90.09Consensus RatingModerate Buy Company Overview Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania. Read More Globus Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks97th Percentile Overall ScoreGMED MarketRank™: Globus Medical scored higher than 97% of companies evaluated by MarketBeat, and ranked 40th out of 919 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.3 / 5Analyst RatingModerate Buy Consensus RatingGlobus Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.62, and is based on 8 buy ratings, 5 hold ratings, and no sell ratings.Amount of Analyst CoverageGlobus Medical has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Globus Medical's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth17.15% Earnings GrowthEarnings for Globus Medical are expected to grow by 17.15% in the coming year, from $3.44 to $4.03 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Globus Medical is 39.25, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 28.11.Price to Earnings Ratio vs. SectorThe P/E ratio of Globus Medical is 39.25, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.86.Price to Earnings Growth RatioGlobus Medical has a PEG Ratio of 1.54. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioGlobus Medical has a P/B Ratio of 1.73. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Globus Medical's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.34% of the outstanding shares of Globus Medical have been sold short.Short Interest Ratio / Days to CoverGlobus Medical has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Globus Medical has recently increased by 4.87%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldGlobus Medical does not currently pay a dividend.Dividend GrowthGlobus Medical does not have a long track record of dividend growth. Sustainability and ESG4.1 / 5Environmental Score-0.93 Percentage of Shares Shorted3.34% of the outstanding shares of Globus Medical have been sold short.Short Interest Ratio / Days to CoverGlobus Medical has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Globus Medical has recently increased by 4.87%, indicating that investor sentiment is decreasing. News and Social Media3.8 / 5News Sentiment0.81 News SentimentGlobus Medical has a news sentiment score of 0.81. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.45 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 17 news articles for Globus Medical this week, compared to 12 articles on an average week.Search Interest9 people have searched for GMED on MarketBeat in the last 30 days. This is an increase of 350% compared to the previous 30 days.MarketBeat Follows3 people have added Globus Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Globus Medical insiders have not sold or bought any company stock.Percentage Held by Insiders18.51% of the stock of Globus Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions95.16% of the stock of Globus Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Globus Medical's insider trading history. Receive GMED Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Globus Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address GMED Stock News HeadlinesCanaccord Downgrades Globus Medical (GMED) PT to $90, Maintains Buy RatingJuly 28, 2025 | msn.comQ2 EPS Estimates for Globus Medical Cut by Zacks ResearchJuly 28, 2025 | americanbankingnews.comMicrosoft's Next Big Bet?Microsoft just broke ground on a revolutionary power system that could deliver virtually limitless, carbon-free energy. Bill Gates calls it “abundant” and is backing four separate startups in the space. While most of these plays are off-limits to everyday investors, a little-known backdoor could give you access to one tiny company leading the charge—and it’s publicly traded.August 2 at 2:00 AM | Stansberry Research (Ad)Q2 EPS Estimates for Globus Medical Increased by AnalystJuly 26, 2025 | americanbankingnews.comGlobus Medical Introduces DuraPro with Navigation to Enhance Surgical Workflows, SafetyJuly 25, 2025 | msn.comGlobus Medical's (GMED) Hold Rating Reiterated at Needham & Company LLCJuly 23, 2025 | americanbankingnews.comHold Rating Maintained for Globus Medical Amid CEO Transition and Growth ConcernsJuly 21, 2025 | tipranks.comReflecting On Medical Devices & Supplies - Specialty Stocks’ Q1 Earnings: Integer Holdings (NYSE:ITGR)July 21, 2025 | msn.comSee More Headlines GMED Stock Analysis - Frequently Asked Questions How have GMED shares performed this year? Globus Medical's stock was trading at $82.71 at the beginning of the year. Since then, GMED stock has decreased by 36.4% and is now trading at $52.60. How were Globus Medical's earnings last quarter? Globus Medical, Inc. (NYSE:GMED) released its quarterly earnings data on Thursday, May, 8th. The medical device company reported $0.68 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.74 by $0.06. The firm's quarterly revenue was down 1.4% compared to the same quarter last year. Read the conference call transcript. Is Globus Medical buying back stock? Globus Medical's Board of Directors approved a stock buyback program on Thursday, May 15th 2025, which authorizes the company to buy back $500,000,000 in shares, according to EventVestor. This means that the company could purchase up to 6.3% of its shares through open market purchases. Shares repurchase programs are typically a sign that the company's management believes its shares are undervalued. Who are Globus Medical's major shareholders? Globus Medical's top institutional shareholders include William Blair Investment Management LLC (1.78%), Stephens Investment Management Group LLC (0.48%), Swedbank AB (0.46%) and Vaughan Nelson Investment Management L.P. (0.43%). Insiders that own company stock include David D Davidar, Ann D Rhoads, Leslie V Norwalk, Kelly Huller, Keith W Pfeil, Daniel T Scavilla and Dan Lemaitre. View institutional ownership trends. How do I buy shares of Globus Medical? Shares of GMED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Globus Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Globus Medical investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), CrowdStrike (CRWD), Arista Networks (ANET), Advanced Micro Devices (AMD) and ServiceNow (NOW). Company Calendar Last Earnings5/08/2025Today8/02/2025Next Earnings (Estimated)8/07/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry MED INSTRUMENTS Sub-IndustryHealth Care Equipment Current SymbolNYSE:GMED CIK1237831 Webwww.globusmedical.com Phone(610) 930-1800Fax610-930-2042Employees5,300Year FoundedN/APrice Target and Rating Average Price Target for Globus Medical$90.09 High Price Target$115.00 Low Price Target$68.00 Potential Upside/Downside+71.3%Consensus RatingModerate Buy Rating Score (0-4)2.62 Research Coverage13 Analysts Profitability EPS (Trailing Twelve Months)$1.34 Trailing P/E Ratio39.25 Forward P/E Ratio15.29 P/E Growth1.54Net Income$102.98 million Net Margins7.39% Pretax Margin9.28% Return on Equity10.52% Return on Assets8.56% Debt Debt-to-Equity RatioN/A Current Ratio4.45 Quick Ratio2.72 Sales & Book Value Annual Sales$2.52 billion Price / Sales2.83 Cash Flow$6.66 per share Price / Cash Flow7.90 Book Value$30.40 per share Price / Book1.73Miscellaneous Outstanding Shares135,380,000Free Float110,320,000Market Cap$7.12 billion OptionableOptionable Beta1.20 Social Links Beginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (NYSE:GMED) was last updated on 8/2/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...Timothy Sykes | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredDon’t Touch Tesla Stock Without Reading This FirstJeff Brown says he wouldn’t touch Tesla stock right now—and the reason might shock you. A 40-year Wall Stre...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Globus Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Globus Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.